Scarica l'app Stockscreener
3.0101
0.96%
-0.0999
Precedente Chiudi:
$3.11
Aprire:
$3.14
Volume 24 ore:
97,920
Relative Volume:
0.09
Capitalizzazione di mercato:
$2.48M
Reddito:
$3,000
Utile/perdita netta:
$-5.65M
Rapporto P/E:
-2.404
EPS:
-1.2521
Flusso di cassa netto:
$-5.88M
1 W Prestazione:
+4.76%
1M Prestazione:
-42.02%
6M Prestazione:
-69.58%
1 anno Prestazione:
-85.67%
Intervallo 1D:
$3.02
$3.364
Intervallo di 1 settimana:
$2.57
$3.364
Portata 52W:
$2.50
$28.50
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Nome
Virax Biolabs Group Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare VRAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
3.11 | 2.49M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
524.21 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
668.24 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
925.94 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.13 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.01 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Iniziato | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Borsa (VRAX) Ultime notizie
Virax Biolabs | 20-F: Registration statement / Annual report / Transition report - Moomoo
Virax Biolabs Company Profile & Introduction - Moomoo
Virax Biolabs : Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F) - marketscreener.com
[20-F] Virax Biolabs Group Ltd Files Annual Report (Foreign Issuer) | VRAX SEC FilingForm 20-F - Stock Titan
Virax Biolabs Approves 1-for-25 Share Consolidation to Maintain Nasdaq Listing - TipRanks
Virax Biolabs (NASDAQ: VRAX) enacts 1-for-25 share consolidation to meet Nasdaq bid rule - Stock Titan
Virax Biolabs (VRAX) Implements 1-for-25 Share Consolidation to Sustain Nasdaq Listing - GuruFocus
Virax Biolabs announces 1-for-25 reverse stock split - Investing.com
Virax Biolabs announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia
Virax Biolabs cuts shares 25-to-1 to try to keep Nasdaq listing - Stock Titan
Virax Biolabs Group Ltd (VRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Virax Biolabs Group Ltd (VRAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Virax Biolabs Group Ltd (VRAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Virax Biolabs Group Ltd (VRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Virax Biolabs Group Ltd (VRAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Virax Biolabs Group Ltd (VRAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Virax Biolabs Group Ltd (VRAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Virax Biolabs Group Ltd (VRAX) Institutional Confidence - TradingKey
Virax Biolabs Group Ltd (VRAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
These stocks are moving in today's after hours session - ChartMill
Virax Biolabs Shareholders Approve Reverse Split and Amended Charter at June 12 Meeting - TipRanks
Virax Biolabs (VRAX) investors approve reverse split range and new charter - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
What's going on in today's after hours session - ChartMill
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch - marketscreener.com
Virax Biolabs (VRAX) Shows Promising Data for Long COVID Test - GuruFocus
Virax Biolabs reports positive pilot data for long COVID blood test - grafa.com
Virax Biolabs Reports Strong Early Data for Long COVID Test and Prepares Larger Validation Study - TipRanks
VRAXVirax Biolabs Group Ltd Stock Price and Quote - Finviz
Virax Biolabs (NASDAQ: VRAX) reports positive ViraxImmune Long COVID data - Stock Titan
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes - Yahoo Finance
Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week - Bez Kabli
Virax Biolabs Calls June 5 EGM to Approve Reverse Share Split and Charter Amendments - The Globe and Mail
Virax Biolabs (NASDAQ: VRAX) seeks 10–30 for 1 reverse split to meet Nasdaq bid rule - Stock Titan
BC-most active stocks - MSN
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Nasdaq most active stocks: - MSN
Which stocks are most active on Tuesday? - ChartMill
In today's session, these stocks are experiencing unusual volume. - ChartMill
Let's take a look at the stocks that are in motion in today's session. - ChartMill
Wondering what's happening in today's pre-market session? - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Nasdaq Down 200 Points; Brady Earnings Top Views - Sahm
Why Is Virax Biolabs (VRAX) Stock Trending Overnight? - Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
These stocks are moving in today's session - ChartMill
Virax Biolabs Group Limited Surges 83.8% on Heavy Trading Volume - Meyka
Monday's session: most active stocks - ChartMill
Let's have a look at the top gainers and losers in the middle of the day of today's session. - ChartMill
Virax Biolabs (VRAX) Surges 177% as Low-float Momentum Meets Extreme Short Interest - Moomoo
Virax Biolabs (VRAX) surges 177% as low-float momentum meets extreme short interest - Quiver Quantitative
Virax Biolabs Group Ltd Azioni (VRAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.16%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):